Results 1 to 10 of about 42,026 (190)

Antinuclear antibodies in COVID 19 [PDF]

open access: yesClinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al. on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19). Both we and Chang and collaborators described the presence and significance of ANAs in patients with COVID‐19.
Paolo Muratori   +3 more
doaj   +4 more sources

Understanding antinuclear antibodies [PDF]

open access: hybridThe Journal of the American Osteopathic Association, 1991
The American College of Rheumatology (formerly the American Rheumatism Association) diagnostic criteria for connective tissue disorders frequently include positive antinuclear antibody (ANA) assays. Proper interpretation of these tests requires an understanding of the principles governing ANA assays.
Raymond M. Pertusi, Bernard R. Rubin
openalex   +4 more sources

ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA [PDF]

open access: bronzeThe Journal of Experimental Medicine, 1966
Antinuclear antibodies were detected by immunofluorescence in most sera from rabbits immunized with whole human serum emulsified in Freund's complete adjuvant. Four of 14 sera from rabbits immunized with Cohn fractions III, IV-1, or IV-4 also gave positive nuclear fluorescence with human leukocyte nuclei.
Eugene V. Barnett, John H. Vaughan
openalex   +4 more sources

Can Antinuclear Antibodies (ANA) be Monoclonal? [PDF]

open access: yesCase Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman   +7 more
doaj   +2 more sources

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

open access: yesIndian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti   +5 more
doaj   +2 more sources

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students [PDF]

open access: yesJournal of Primary Care & Community Health
Introduction: Antinuclear antibodies (ANA) are the hallmark of many connective tissue disorders (including lupus), which comprise roughly 5% to 10% of chronic debilitating diseases causing morbidity and mortality.
Karol Laskowski   +4 more
doaj   +2 more sources

Antinuclear antibodies and endometriosis [PDF]

open access: bronzeInternational Journal of Gynecology & Obstetrics, 2006
Endometriosis is characterized by the implant growth and development of endometrial tissue in an extrauterine location. Approximately 5—15% of women present the disease during the reproductive years. Various immunological alterations could explain the development of endometriosis.
João Dias   +2 more
openalex   +4 more sources

The Past, Present, and Future in Antinuclear Antibodies (ANA) [PDF]

open access: yesDiagnostics, 2022
Autoantibodies are a hallmark of autoimmunity and, specifically, antinuclear antibodies (ANAs) are the most relevant autoantibodies present in systemic autoimmune rheumatic diseases (SARDs).
Juan Irure-Ventura, Marcos López-Hoyos
doaj   +2 more sources

Home - About - Disclaimer - Privacy